-
-
L-(+)-Tartaric acid solution,15%(w/v), 1L
-
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-amino-2-methyl-4-oxobutanoic acid,97%, 100mg
-
(1S)-(+)-10-Camphorsulfonic acid,10mM in DMSO, 1ml
-
(2R,4S)-1-(tert-Butoxycarbonyl)-4-
phenylpyrrolidine-2-carboxylic acid,97%, 1g
-
2,6,6-Trimethyl-1,3-Cyclohexadiene-1-Carboxaldehyde,90%, with stabilizer alpha-tocopherol, 1g
-
2,6,6-Trimethyl-1,3-Cyclohexadiene-1-Carboxaldehyde,90%, with stabilizer alpha-tocopherol, 5g
-
2,6,6-Trimethyl-1,3-Cyclohexadiene-1-Carboxaldehyde,90%, with stabilizer alpha-tocopherol, 25g
-
N-[(1,1-Dimethylethoxy)carbonyl]-5,5,5-trifluoro-D-norvaline,98%, 1g
-
(S)-3-(((benzyloxy)carbonyl)amino)-2-
phenylpropanoic acid,98%, 100mg
-
(S)-3-(((benzyloxy)carbonyl)amino)-2-
phenylpropanoic acid,98%, 250mg
-
(S)-3-(((benzyloxy)carbonyl)amino)-2-
phenylpropanoic acid,98%, 1g
стр.: